US · guidance
CMS Pub. 100-04, ch. 32, § 90.1
General
Allogeneic Stem Cell Transplantation.
Allogeneic stem cell transplantation is a procedure in which a portion of a healthy donor’s stem cells is
obtained and prepared for intravenous infusion to restore normal hematopoietic function in recipients having
an inherited or acquired hematopoietic deficiency or defect.
Expenses incurred by a donor are a covered benefit to the recipient/beneficiary but, except for physician
services, are not paid separately. Services to the donor include physician services, hospital care in connection
with screening the stem cell, and ordinary follow-up care.
Autologous Stem Cell Transplantation
Autologous stem cell transplantations is a technique for restoring stem cells using the patient’s own previously
stored cells. Autologous stem cell transplants are covered for certain specified diagnoses for services rendered
on or after April 28, 1989.
History
(Rev. 486, Issued: 03-04-05, Effective Date/Implementation Date: N/A)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
93f9b1778c82836ae631161ffa29e81c06901470957b46647d9ead40e488b06c
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.